Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127735891 | 12773589 | 1 | I | 20140224 | 20140303 | 20160923 | 20160923 | EXP | GB-ROCHE-1358883 | ROCHE | 66.20 | YR | F | Y | 58.80000 | KG | 20160923 | MD | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127735891 | 12773589 | 1 | PS | Rituximab | RITUXIMAB | 1 | Intravenous (not otherwise specified) | 103705 | 600 | MG | SOLUTION FOR INFUSION | ||||||||
| 127735891 | 12773589 | 2 | SS | Rituximab | RITUXIMAB | 1 | Subcutaneous | Y | 103705 | 1400 | MG | SOLUTION FOR INJECTION | |||||||
| 127735891 | 12773589 | 3 | SS | FLUDARABINE | FLUDARABINE PHOSPHATE | 1 | Oral | 0 | 40 | MG | |||||||||
| 127735891 | 12773589 | 4 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Oral | 0 | 200 | MG | |||||||||
| 127735891 | 12773589 | 5 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | 0 | 300 | MG | |||||||||
| 127735891 | 12773589 | 6 | C | PARACETAMOL | ACETAMINOPHEN | 1 | Oral | 0 | 1000 | MG | |||||||||
| 127735891 | 12773589 | 7 | C | CHLORPHENAMINE | CHLORPHENIRAMINE MALEATE | 1 | Intravenous (not otherwise specified) | 0 | 10 | MG | |||||||||
| 127735891 | 12773589 | 8 | C | HYDROCORTISONE. | HYDROCORTISONE | 1 | Intravenous (not otherwise specified) | 0 | |||||||||||
| 127735891 | 12773589 | 9 | C | COTRIMOXAZOLE | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Oral | 0 | 480 | MG | |||||||||
| 127735891 | 12773589 | 10 | C | NAPROXEN. | NAPROXEN | 1 | Oral | 0 | 500 | MG | |||||||||
| 127735891 | 12773589 | 11 | C | DALPARAN | ZOLPIDEM TARTRATE | 1 | Subcutaneous | 0 | 5000 | IU | QD | ||||||||
| 127735891 | 12773589 | 12 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 0 | 40 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127735891 | 12773589 | 1 | B-cell lymphoma |
| 127735891 | 12773589 | 2 | B-cell lymphoma |
| 127735891 | 12773589 | 3 | B-cell lymphoma |
| 127735891 | 12773589 | 4 | B-cell lymphoma |
| 127735891 | 12773589 | 5 | B-cell lymphoma |
| 127735891 | 12773589 | 6 | B-cell lymphoma |
| 127735891 | 12773589 | 7 | Prophylaxis |
| 127735891 | 12773589 | 9 | B-cell lymphoma |
| 127735891 | 12773589 | 10 | Pain |
| 127735891 | 12773589 | 11 | Prophylaxis |
| 127735891 | 12773589 | 12 | Oedema |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127735891 | 12773589 | OT |
| 127735891 | 12773589 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127735891 | 12773589 | Bronchiectasis | |
| 127735891 | 12773589 | Cellulitis | |
| 127735891 | 12773589 | Lung infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127735891 | 12773589 | 1 | 20140218 | 20140218 | 0 | |
| 127735891 | 12773589 | 2 | 20140218 | 20160705 | 0 | |
| 127735891 | 12773589 | 3 | 20140218 | 20140513 | 0 | |
| 127735891 | 12773589 | 4 | 20140218 | 20140513 | 0 | |
| 127735891 | 12773589 | 5 | 20140218 | 20140224 | 0 | |
| 127735891 | 12773589 | 6 | 20140218 | 20160705 | 0 | |
| 127735891 | 12773589 | 7 | 20140218 | 20140218 | 0 | |
| 127735891 | 12773589 | 8 | 20140218 | 20140218 | 0 | |
| 127735891 | 12773589 | 9 | 20140218 | 20140804 | 0 | |
| 127735891 | 12773589 | 10 | 20120330 | 0 | ||
| 127735891 | 12773589 | 11 | 20140221 | 20140222 | 0 | |
| 127735891 | 12773589 | 12 | 20140228 | 0 |